down-chev
down-chev

WE ARE A PRECISION DRUG DEVELOPMENT COMPANY FOCUSED ON ONCOLOGY

Our purpose is to accelerate the development of cancer medicines and treatments

Talk to our team

We’d like to hear from you

Read the latest news from Ellipses Pharma

Streamlining drug development processes

Ellipses Pharma features in the Guardian Innovations In Oncology and Imaging Series As part of The Guardian's Innovations in Oncology and Imaging series, our CEO Rajan Jethwa, CMO Professor Tobi Arkenau and Head of CMC Graeme Horne explain how our streamlined approach to drug development is meeting patients' needs quicker. To read the full article [...]

Accelerating development of critical cancer drugs

Ellipses Pharma features in the Guardian Innovations In Oncology and Imaging Series As part of The Guardian's Innovations in Oncology and Imaging series, our Chairman and Co-Founder Professor Sir Chris Evans OBE, and our CMO Professor Tobi Arkenau explain how our unique and disruptive drug development model is accelerating the development of potential new cancer [...]

Our unique approach to developing cancer medicines faster

Ellipses Pharma on our unique approach to developing cancer medicines faster Hear from our Chairman, Professor Sir Chris Evans, our CEO, Dr Rajan Jethwa and our Global Head of Drug Development, Professor Tobi Arkenau alongside other industry experts and get a look inside Ellipses to discover how our unique approach develops cancer medicines faster. This [...]